Mainz Biomed B.V. (MYNZ) NASDAQ

1.64

+0.005(+0.31%)

Updated at September 08 03:04PM

Currency In USD

Mainz Biomed B.V.

Address

Robert Koch Strasse 50

Mainz, 55129

Germany

Phone

49 6131 554 2860

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

19

First IPO Date

November 05, 2021

Key Executives

NameTitlePayYear Born
Mr. Guido BaechlerChief Executive Officer & Executive Director01965
Mr. Stefan ErlachHead of Human Resources0N/A
Dr. Frank Krieg-SchneiderChief Technology Officer01962
Dr. Christopher Von Toerne P.M.P., Ph.D.Chief Operating Officer01972
Dr. Moritz Eidens Ph.D.Chief Science Officer & Executive Director01984
Mr. Philipp FreeseChief Business Officer01983

Description

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.